Skip to main content
Log in

Cost Effectiveness of Different Central Venous Approaches for Port Placement and Use in Adult Oncology Patients: Evidence From a Randomized Three-Arm Trial

  • Healthcare Policy and Outcomes
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

No randomized trials have so far investigated the cost effectiveness of different methods for implantation and use of central venous ports in oncology patients.

Patients and Methods

Overall, 403 patients eligible for receiving intravenous chemotherapy for solid tumours were randomly assigned to implantation of a single type of port, either through a percutaneous landmark access to the internal jugular vein, an ultrasound (US)-guided access to the subclavian vein, or a surgical cut-down access through the cephalic vein at the deltoid-pectoralis groove. Insertion and maintenance costs were estimated by obtaining the charges for an average implant and use, while the costs of the management of complications were analytically assessed. The total cost was defined as the purchase cost plus the insertion cost plus the maintenance cost plus the cost of treatment of the complications, if any.

Results

A total of 401 patients were evaluable—132 with the internal jugular vein, 136 with the subclavian vein and 133 with the cephalic vein access. No differences were found for the rate of early complications. The US-guided subclavian insertion site had significantly lower failures. Infections occurred in 1, 3, and 3 patients (internal jugular, subclavian, and cephalic access, respectively; p = 0.464), whereas venous thrombosis was observed in 15, 8, and 11 patients, respectively (p = 0.272). Mean cost for purchase, implantation, diagnosis and treatment of complications in each patient was €2,167.85 for subclavian US-guided, €2,335.87 for cephalic, and €2,384.10 for internal jugular access, respectively (p = 0.0001).

Conclusion

US real-time guidance to the subclavian vein resulted in the most cost-effective method of central venous port placement and use.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Biffi R, Corrado F, De Braud F, et al. Long term, totally implantable central venous access ports connected to Groshong catheter for chemotherapy of solid tumours: experience on 178 cases using a single type of device. Eur J Cancer. 1997;33:1190–1194.

    Article  PubMed  CAS  Google Scholar 

  2. Biffi R, De Braud F, Orsi F, et al. A randomized, prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adult oncology patients. Cancer. 2001;92:1204–1212.

    Article  PubMed  CAS  Google Scholar 

  3. Biffi R, Orsi F, Pozzi S, et al. Best choice of central venous insertion site for the prevention of catheter-related complications in adult patients who need cancer therapy: a randomized trial. Ann Oncol. 2009;20:935–940.

    Article  PubMed  CAS  Google Scholar 

  4. Biffi R, Orsi F, Pozzi S, et al. No impact of central venous insertion site on oncology patients’ quality of life and psychological distress: a randomized three-arm trial. Support Care Cancer. 2011;19(10):1573–1580.

    Article  PubMed  Google Scholar 

  5. Sticca RP, Dewing BD, Harris JD. Cost issues. In: Di Carlo I, Biffi R, editors. Totally implantable venous access devices. Springer-Verlag Italia;2011.

    Google Scholar 

  6. Biffi R, de Braud F, Orsi F, et al. Totally implantable central venous access ports for long term chemotherapy: a prospective study analysing complications and costs in 333 devices with a minimum 180 days of follow-up. Ann Oncol. 1998;9:767–773.

    Article  PubMed  CAS  Google Scholar 

  7. Sticca RP, Dewing BD, Harris JD. Outcomes of surgical and radiologic placed implantable central venous access ports. Am J Surg. 2009;198:829–833.

    Article  PubMed  Google Scholar 

  8. Ignatov A, Hoffman O, Smith B, et al. An 11-year retrospective study of totally implanted central venous access ports: complications and patient satisfaction. Eur J Surg Oncol. 2009;35:241–246.

    Article  PubMed  CAS  Google Scholar 

  9. Hancock HR, Connolly BL, McMahon M, et al. Cost-effectiveness analysis of implantable venous access device insertion using interventional radiologic versus conventional operating room methods in pediatric patients with cancer. J Vasc Interv Radiol. 2010;5:677–684.

    Article  Google Scholar 

  10. Marcy PY, Magné N, Castadot P, et al. Radiological and surgical placement of port devices: a 4-year institutional analysis of procedure performance, quality of life and cost in breast cancer patients. Breast Cancer Res Treat. 2005;92:61–67.

    Article  PubMed  Google Scholar 

  11. Liu GF, Wang J, Liu K, Snavely DB. Confidence intervals for an exposure adjusted incidence rate difference with applications to clinical trials. Stat Med. 2006;25:1275–1286.

    Article  PubMed  Google Scholar 

  12. O’Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics. 1979;35:549–556.

    Article  PubMed  Google Scholar 

  13. Gallieni M, Pittiruti M, Biffi R. Vascular access in oncology patients. CA Cancer J Clin. 2008;58:323–346.

    Article  PubMed  Google Scholar 

  14. Kreis H, Loehberg CR, Lux MP, et al.Patients’ attitudes to totally implantable venous access port systems for gynecological or breast malignancies. Eur J Surg Oncol. 2007;33:39–43.

    Article  PubMed  CAS  Google Scholar 

  15. Mueller BU, Skelton J, Callender DP. A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer patients. J Clin Oncol. 1992;10:1943–1948.

    PubMed  CAS  Google Scholar 

  16. Ng F, Mastoroudes H, Paul E, et al. A comparison of Hickman line and Port-a-Cath associated complications in patients with solid tumours undergoing chemotherapy. Clin Oncol (R Coll Radiol). 2007;19:551–556.

    Article  PubMed  CAS  Google Scholar 

  17. Hind D, Caivert N, McWilliams R, et al. Ultrasonic locating devices for central venous cannulation: meta-analysis. BMJ. 2003;327:361–367.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Calvert N, Hind D, McWilliams R, et al. Ultrasound for central venous cannulation: economic evaluation of cost-effectiveness. Anaesthesia. 2004;59:1116–1120.

    Article  PubMed  CAS  Google Scholar 

  19. Biffi R, Pozzi S, Cenciarelli S, et al. Treatment of pneumothorax as a complication of long-term central venous port placement in oncology patients: an observational study. J Vasc Access. 2001;2(3):129–136.

    PubMed  CAS  Google Scholar 

  20. Kim JS, Holtom P, Vigen C. Reduction of catheter-related bloodstream infections through the use of a central venous line bundle: epidemiologic and economic consequences. Am J Infect Control. 2011;39(8):640–646.

    Article  PubMed  Google Scholar 

  21. Cooper K, Frampton G, Harris P, et al. Are educational interventions to prevent catheter-related bloodstream infections in intensive care unit cost-effective? J Hosp Infect. 2014;86(1):47–52.

    Article  PubMed  CAS  Google Scholar 

  22. Maki DG, Kluger DM, Crnich CJ. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clinic Proc. 2006;81:1159–1171.

    Article  Google Scholar 

  23. Vescia S, Baumgärtner AK, Jacobs VR, et al. Management of venous port systems in oncology: a review of current evidence. Ann Oncol. 2008;19:9–15.

    Article  PubMed  CAS  Google Scholar 

  24. Verso M, Agnelli G. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. J Clin Oncol. 2003;21:3665–3675.

    Article  PubMed  Google Scholar 

  25. Akl EA, Kamath G, Yosuico V, et al. Thromboprophylaxis for patients with cancer and central venous catheters: a systematic review and a meta-analysis. Cancer. 2008;112:2483–2492.

    Article  PubMed  CAS  Google Scholar 

  26. Chaukiyal P, Nautiyal A, Radhakrishnan S, et al. Thromboprophylaxis in cancer patients with central venous catheters: a systematic review and meta-analysis. Thromb Haemost. 2008;99:38–43.

    PubMed  CAS  Google Scholar 

Download references

Acknowledgment

This study has been supported by a biennial research grant from AIRC—Associazione Italiana per la Ricerca sul Cancro (Italian Association for Cancer Research), Grant Application Number 1126. Bard Italia, Rome, offered technical support for this study.

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Roberto Biffi MD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Biffi, R., Pozzi, S., Bonomo, G. et al. Cost Effectiveness of Different Central Venous Approaches for Port Placement and Use in Adult Oncology Patients: Evidence From a Randomized Three-Arm Trial. Ann Surg Oncol 21, 3725–3731 (2014). https://doi.org/10.1245/s10434-014-3784-5

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-014-3784-5

Keywords

Navigation